A histone deacetylase inhibitor, azelaic bishydroxamic acid, shows cytotoxicity on Epstein-Barr virus transformed B-cell lines: a potential therapy for posttransplant lymphoproliferative disease (Q40753352)
Jump to navigation
Jump to search
scientific article published on January 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A histone deacetylase inhibitor, azelaic bishydroxamic acid, shows cytotoxicity on Epstein-Barr virus transformed B-cell lines: a potential therapy for posttransplant lymphoproliferative disease |
scientific article published on January 2002 |
Statements
1 reference
A histone deacetylase inhibitor, azelaic bishydroxamic acid, shows cytotoxicity on Epstein-Barr virus transformed B-cell lines: a potential therapy for posttransplant lymphoproliferative disease (English)
1 reference
1 reference
Tom B Sculley
1 reference
Marion Buck
1 reference
Brian Gabrielli
1 reference
Kenia G Krauer
1 reference
1 January 2002
1 reference
1 reference
Identifiers
1 reference